Detalles de la búsqueda
1.
Leukocyte-associated immunoglobulin-like receptor-1 blockade in combination with programmed death-ligand 1 targeting therapy mediates increased tumour control in mice.
Cancer Immunol Immunother
; 73(1): 16, 2024 Jan 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-38236251
2.
Characterization of human Fc alpha receptor transgenic mice: comparison of CD89 expression and antibody-dependent tumor killing between mouse strains.
Cancer Immunol Immunother
; 72(9): 3063-3077, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37338671
3.
Enhancement of epidermal growth factor receptor antibody tumor immunotherapy by glutaminyl cyclase inhibition to interfere with CD47/signal regulatory protein alpha interactions.
Cancer Sci
; 112(8): 3029-3040, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34058788
4.
The Therapeutic CD38 Monoclonal Antibody Daratumumab Induces Programmed Cell Death via Fcγ Receptor-Mediated Cross-Linking.
J Immunol
; 197(3): 807-13, 2016 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27316683
5.
FcRγ-chain ITAM signaling is critically required for cross-presentation of soluble antibody-antigen complexes by dendritic cells.
J Immunol
; 193(11): 5506-14, 2014 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-25355925
6.
Effector mechanisms of IgA antibodies against CD20 include recruitment of myeloid cells for antibody-dependent cell-mediated cytotoxicity and complement-dependent cytotoxicity.
Br J Haematol
; 181(3): 413-417, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-28449349
7.
Sialic Acids on Tumor Cells Modulate IgA Therapy by Neutrophils via Inhibitory Receptors Siglec-7 and Siglec-9.
Cancers (Basel)
; 15(13)2023 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-37444515
8.
Disruption of the sialic acid/Siglec-9 axis improves antibody-mediated neutrophil cytotoxicity towards tumor cells.
Front Immunol
; 14: 1178817, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37346044
9.
Effective, Long-Term, Neutrophil Depletion Using a Murinized Anti-Ly-6G 1A8 Antibody.
Cells
; 11(21)2022 10 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-36359801
10.
The in vivo mechanism of action of CD20 monoclonal antibodies depends on local tumor burden.
Haematologica
; 96(12): 1822-30, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21880632
11.
The selection of variable regions affects effector mechanisms of IgA antibodies against CD20.
Blood Adv
; 5(19): 3807-3820, 2021 10 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34525171
12.
Bovine IgG Prevents Experimental Infection With RSV and Facilitates Human T Cell Responses to RSV.
Front Immunol
; 11: 1701, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32849597
13.
Novel chimerized IgA CD20 antibodies: Improving neutrophil activation against CD20-positive malignancies.
MAbs
; 12(1): 1795505, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32744145
14.
IgA-Mediated Killing of Tumor Cells by Neutrophils Is Enhanced by CD47-SIRPα Checkpoint Inhibition.
Cancer Immunol Res
; 8(1): 120-130, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31690649
15.
Potent Fc Receptor Signaling by IgA Leads to Superior Killing of Cancer Cells by Neutrophils Compared to IgG.
Front Immunol
; 10: 704, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31031746
16.
Immune Effector Functions of Human IgG2 Antibodies against EGFR.
Mol Cancer Ther
; 18(1): 75-88, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30282813
17.
Glutaminyl cyclase is an enzymatic modifier of the CD47- SIRPα axis and a target for cancer immunotherapy.
Nat Med
; 25(4): 612-619, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30833751
18.
Reformatting palivizumab and motavizumab from IgG to human IgA impairs their efficacy against RSV infection in vitro and in vivo.
MAbs
; 10(3): 453-462, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29553863
19.
Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting.
MAbs
; 8(1): 87-98, 2016.
Artículo
en Inglés
| MEDLINE | ID: mdl-26466856
20.
An Anti-EGFR IgA That Displays Improved Pharmacokinetics and Myeloid Effector Cell Engagement In Vivo.
Cancer Res
; 76(2): 403-17, 2016 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-26634925